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To identify cellular factors that interact with hepatitis C virus RNA, cellular extracts were subjected to UV cross-linking to
radiolabeled RNAs corresponding to the hepatitis C virus 59 and 39 untranslated regions of positive and negative polarities.
Our results demonstrate that the U-rich region of the hepatitis C virus 39 untranslated region of the positive RNA strand is
a hot spot for cellular RNA binding proteins. Two of these proteins were identified as the ELAV-like HuR protein and hnRNP
C. Interestingly, HuR and hnRNP C also interacted with the 39 end of the RNA representing the negative strand of the HCV
genome. The binding of HuR and hnRNP C to the 39 ends of the HCV RNAs of both negative and positive polarities suggests
that HuR and hnRNP C may be involved in the transcription of the HCV RNA genome. Alternatively, they act by protecting the
HCV RNAs from premature degradation by binding to their 39 ends. However, we were unable to demonstrate an effect on
HCV RNA stability by the HuR protein. These interactions may be necessary for the establishment of chronic active infections
a. © 2that may develop into cirrhosis or hepatocellular carcinom
INTRODUCTION
Hepatitis C virus (HCV), a member of the Flaviviridae
family (Houghton, 1996; Rice, 1996), is the principal agent
of non-A non-B hepatitis. Infections become chronic in
more than 50% of patients and commonly result in
chronic active hepatitis that may develop into liver cir-
rhosis and hepatocellular carcinoma (Houghton, 1996).
HCV is a major human pathogen that is spread world-
wide but vaccines or effective antiviral drugs are not yet
available. It has been estimated that up to 170 million
individuals may be infected worldwide (Cohen, 1999).
Approximately 85% of the infected individuals develop a
chronic, life-long infection that results in cirrhosis within
a 20-year period in 30% of the cases. Among patients
with cirrhosis, the yearly incidence of hepatocellular car-
cinoma is 1–4% (Cohen, 1999). The lack of a cell culture
system for propagation of HCV in vitro has hampered the
development of antiviral drugs against HCV. It is there-
fore of interest to study the requirements for HCV repli-
cation.
The HCV genome is approximately 9.5 kilobases (kb)
and contains a unique open-reading frame (ORF) that is
translated into a polyprotein which is cleaved cotransla-
tionally into functional products by viral and cellular pro-
teases (Clark, 1997; Reed and Rice, 1998; Rice, 1996; van
Dorn, 1994). The ORF is flanked by the 59 and 39 untrans-
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lated regions (UTRs) that are involved in transcription
and translation initiation (Clark, 1997; Reed and Rice,
1998; Rice, 1996; van Dorn, 1994). These sequences
contain important cis-acting elements that interact with
cellular and viral factors and are essential for completion
of the virus life cycle. The HCV 59 UTR contains an
internal ribosome entry site (IRES) for internal initiation of
translation (Clark, 1997; Lemon and Honda, 1997; Reed
and Rice, 1998; van Dorn, 1994). The HCV IRES is a highly
structured RNA sequence that extends into the capsid
coding region (Reynolds et al., 1995) and folds into a
structure that appears to be conserved among various
HCV genotypes (Brown et al., 1992; Bukh et al., 1992;
Tsukiyama-Kohara et al., 1992). RNase protection analy-
sis, mutagenesis of the IRES, and analysis of sequences
of naturally occurring HCV subtypes with sequences
deviating from the consensus sequence support the sec-
ondary structure that has been proposed for the HCV 59
UTR (Lemon and Honda, 1997) and maintenance of the
secondary structure of the HCV IRES is a prerequisite for
internal initiation of translation.
The HCV 59 UTR has been shown to interact with
cellular factors (Yen et al., 1995) and five factors have
been identified, e.g., the La protein (Ali and Siddiqui,
1997; Spångberg et al., 1999), the polypyrimidine tract
binding protein (PTB) (Ali and Siddiqui, 1995), hnRNP L
(Hahm et al., 1998), eIF3 (Sizova et al., 1998), and the
poly(C)binding proteins 1 and 2 (Spångberg and
Schwartz, 1999). Depletion of the PTB from an in vitro
translation reaction resulted in inhibition of HCV IRES-
dependent translation (Ali and Siddiqui, 1995), whereas
in other reported experiments this effect was not seen
HuR T(Kaminski et al., 1995). Addition of purified La protein to
an in vitro translation reaction showed a dose-dependent
increase in HCV IRES-directed translation (Ali and Sid-
diqui, 1997), suggesting that La is stimulating translation
of HCV mRNAs. The binding site of the hnRNP L protein
was roughly mapped to the 39 end of the IRES and it was
shown that deletion of this region resulted in impaired
translation (Hahm et al., 1998), suggesting that the
hnRNP L binding site may be important for translation
initiation at the HCV IRES. It has been proposed that the
HCV IRES makes contact directly with the ribosome
through eIF3, acting in a fashion similar to the Shine-
Dalgarno sequence on procaryotic mRNAs (Pestova et
al., 1998; Sizova et al., 1998).
The HCV 39 UTR can be divided into the following
three regions: a variable region, a U-rich region, and at
the immediate 39 end a conserved region (Clark, 1997;
Reed and Rice, 1998; Tanaka et al., 1996; Yamada et al.,
1996). The conserved region folds into three stem-loop
structures (Blight and Rice, 1997; Ito and Lai, 1997;
Kolykhalov et al., 1996). These structures are conserved
among different HCV genotypes (Umlauft et al., 1996),
suggesting that the maintenance of the secondary struc-
ture of the HCV 39 UTR is important for HCV replication.
Deletion of the 39 UTR from an infectious HCV molecular
clone rendered it noninfectious following injection into
chimpanzees (Yanagi et al., 1997), demonstrating that the
39 UTR plays an essential role in the HCV replication
cycle. Interestingly, the HCV 39 UTR has been shown to
enhance translation from the HCV IRES (Ito et al., 1998).
In conclusion, the 59 and 39 UTRs of HCV play important
roles in the HCV replication cycle and it is of interest to
identify cellular factors that interact with these RNA se-
quences in order to elucidate the mechanism of action of
the cis-acting RNA elements located in these regions.
RESULTS
Identification of cellular factors that interact with the
HCV 59 and 39 UTRs
In order to identify cellular factors that interact with the
HCV 59 and 39 UTRs, we performed UV cross-linking with
cytoplasmic HeLa cell extracts to radiolabeled RNAs
corresponding to the sense and the antisense strands of
the HCV 59 and 39 UTRs (Fig. 1A). The results are pre-
sented in Fig. 1B and show that multiple proteins were
detected with the HCV 59 and 39 UTR RNA probes. Two
major bands of 95 and 55 kDa were detected with all
probes (Fig. 1B) and were present in both nuclear and
cytoplasmic fractions (Fig. 1C), suggesting that these
were abundant RNA binding proteins with low or no
sequence-specific RNA binding activity. The 95-kDa pro-
tein that UV-cross-links to probe 39A appears to be the
same protein that cross-links to all four probes (Fig. 1B)
BINDING OFand therefore binds to RNA with low or no sequence
specificity, whereas the 110-kDa protein appears to in-teract with the 39A probe in a sequence-specific manner.
Two primarily nuclear proteins of 60 and 100 kDa were
detected with the sense-strand probe of the HCV 39 UTR
and a 100-kDa protein was detected with the sense-
strand probe of the HCV 59 UTR (Fig. 1C). Proteins of
these sizes were also detected with probes 59A and 39A
(data not shown), suggesting low sequence specificity in
the interaction with RNA. We focused our attention on the
38-kDa protein and the cluster of 40- to 45-kDa proteins
that bound to the antisense strand of the HCV 59 UTR and
to the sense strand of the HCV 39 UTR (Fig. 1B). The
38-kDa protein was distributed equally between the nu-
cleus and the cytoplasm, whereas two proteins in the 40-
to 45-kDa cluster were present primarily in the nuclear
fraction (Fig. 1C). These proteins were also detected in
cytoplasmic extracts from Hep3B cells (Fig. 1D). All ex-
periments included a control without protein to confirm
that bands were not seen in the absence of proteins. As
an additional control, the HCV probe 39S was UV-cross-
linked to cytoplasmic extract and in parallel two reac-
tions without cell extract but with two different concen-
trations of RNaseA were performed. The results revealed
that even at RNaseA concentrations that were 6 times
lower (0.5 mg/ml) than those we normally add to the
reactions (3 mg/ml) (Fig. 1E), the radiolabeled RNA is
completely digested. We concluded that we use an ex-
cess of RNaseA and that it is unlikely that bands de-
tected by the UV-cross-linking method are caused by
incomplete digestion of the radiolabeled RNA probe.
The U-rich region in the HCV 39 UTR is a “hot spot”
for RNA binding proteins
In order to identify the HCV RNA binding proteins we
first focused on the HCV 39 UTR sequence. To determine
the specificity of the interactions between the cellular
factors and the HCV 39S (Fig. 1A), competition experi-
ments were performed using the HCV 39 UTR as specific
competitor and the human papillomavirus type 1 late 39
UTR-derived probe C2 (Sokolowski et al., 1997) as un-
specific competitor. While the 39S RNA competed effi-
ciently with the probe for the 38- and the 40- to 45-kDa
RNA binding proteins and less well for the 55- and
95-kDa proteins (Fig. 2A), the C2 RNA did not compete
for the detected proteins (Fig. 2A), demonstrating a pref-
erential binding of primarily the 38- and 40- to 45-kDa
proteins for the HCV 39 UTR RNA.
Three deletion mutants of the HCV 39 UTR probe 39S
(Fig. 1A) were generated and tested in UV cross-linking.
The results revealed that probe UC, which contains the
U-rich region and the conserved region, detected all
proteins seen with the complete 39 UTR, whereas the
variable region probe failed to detect RNA binding pro-
teins (Fig. 2B). Interestingly, a protein was detected with
379O HCV RNAprobe C, which contains the conserved region (Fig. 2B).
This protein may be PTB since it has been shown pre-
FIG. 1. (A) Schematic drawing of the HCV genome. The internal ribosome entry site and the various regions of the HCV 39 UTR are indicated. The
RNA probes are indicated as arrows and their names are shown next to the arrows. Numbers refer to the nucleotide positions in the infectious,
genomic HCV clone pCV-H77C (Yanagi et al., 1997). (B) UV cross-linking of HeLa cytoplasmic extract to the HCV RNA probes 39S, 39A, 59S, and 59A.
(C) UV cross-linking of HeLa cytoplasmic (CE) and nuclear (NE) extracts to the HCV RNA probes 39S and 59S. The p38- and p40- to 45-kDa proteins
detected with the 39S probe are indicated. (D) UV cross-linking of Hep3B cytoplasmic extract to the HCV RNA probes 39S and 59S. The p38- and p40-
380 SPÅNGBERG, WIKLUND, AND SCHWARTZto 45-kDa proteins detected with the 39S probe are indicated. (E) UV cross-linking reactions were performed in the absence (lanes 1 and 2) or
presence of cytoplasmic extract (lane 3).
FIG. 2. (A) Serially diluted unlabeled HCV 39S RNA or C2 RNA (Sokolowski et al., 1997), derived from the human papillomavirus type 1 late 39 UTR,
was used as competitors in UV-cross-linking reactions between radiolabeled probe 39S and HeLa cytoplasmic extract. The p38- and p40- to 45-kDa
proteins detected with the 39S probe are indicated. CE, UV cross-linking between 39S and HeLa cytoplasmic extract in the absence of 3-fold serially
diluted, unlabeled competitor RNA. The molar excess of the competitor over probe was 3-, 9-, 27-, and 81-fold. (B) UV cross-linking of HeLa
cytoplasmic extract to RNA 39S and various deletion mutants of the 39S probe named V, UC, and C (Fig. 1A). A 55-kDa protein seen UV-cross-linking
to RNA probe C is indicated with an asterisk (*). The p38- and p40- to 45-kDa proteins detected with the 39S probe are indicated. (C) Radiolabeled
probe 39S was UV-cross-linked in the presence or absence of 3-fold serially diluted unlabeled competitor RNAs as indicated in the figure. The molar
381BINDING OF HuR TO HCV RNAexcess of the competitor over probe was 3-, 9-, 27-, and 81-fold. The structures of the unlabeled competitors 39S, V, UC, and C are shown in Fig. 1A.
The p38- and p40- to 45-kDa proteins detected with the 39S probe are indicated.
LUND,FIG. 3. Characterization of the HCV 39 UTR RNA binding proteins. (A)
UV cross-linking of HeLa cytoplasmic extract to RNA probe 39S in the
absence (2) or presence of poly(rA), poly(rU), poly(rG), or poly(rC). The
molar excess of the competitor over probe was 100-fold. The p38- and
p40- to 45-kDa proteins detected with the 39S probe are indicated. (B)
HeLa cell cytoplasmic extracts were applied to HiTrap Q or HiTrap SP
columns as described under Materials and Methods and the
flowthrough fractions were collected and subjected to UV cross-linking
to the HCV RNA probe 39S. (C) HeLa cell cytoplasmic extract was
382 SPÅNGBERG, WIKsubjected to UV cross-linking to the HCV RNA probe 39S in the pres-
ence of the HPV-1-derived RNA competitors XB, which containsviously that PTB binds to this region of the HCV 39 UTR
(Chung and Kaplan, 1999; Ito and Lai, 1997; Luo, 1999;
Tsuchihara et al., 1997).
To confirm the mapping results, a competition exper-
iment was performed in which the various deletion mu-
tants were used as competitors. The results revealed
that the complete 39 UTR competed efficiently for the 95-,
the 40- to 45-, and the 38-kDa proteins and less well for
the 55-kDa protein (Fig. 2C). Similar results were ob-
tained with the UC competitor RNA (Fig. 2C). Competitors
consisting of the variable or conserved region failed to
compete for the detectable proteins. In conclusion, the
U-rich region in the HCV 39 UTR is a “hot spot” for RNA
binding proteins.
Characterization of the HCV 39 UTR RNA binding
proteins
In order to characterize the HCV 39 UTR RNA binding
proteins, competition with poly(rA), (rU), (rG), and (rC)
was performed. The results revealed that the 95-, the 40-
to 45-, and the 38-kDa proteins were poly(rU) binding
whereas the 55-kDa protein bound to the HCV 39 UTR in
the presence of high levels of poly(rU) (Fig. 3A). Cyto-
plasmic extracts were prepared from primary human
liver cells obtained from a human liver biopsy and sub-
jected to fractionation on HiTrap Q and SP columns
(Pharmacia-Biotech). The flowthrough fractions from the
two columns were analyzed in UV-cross-linking assay
with respect to the 38- and 40- to 45-kDa proteins and as
shown in Fig. 3B, the 38-kDa protein was absent in the
flowthrough from the SP column, but was present in the
Q-column flowthrough fraction. Of the 40- to 45-kDa clus-
ter of proteins, one band was detected in the SP
flowthrough and two bands were found in the Q-column
flowthrough fraction (Fig. 3B). In conclusion, the results
demonstrated a negative net charge at pH 7.6 for the
poly(rU) binding, 38-kDa protein and for one of the pro-
teins in the 40- to 45-kDa cluster, and a positive net
charge for two of the proteins in the 40- to 45-kDa cluster.
HuR and hnRNP C interact with the HCV 39 UTR
The 38-kDa protein was identified as a poly(rU) bind-
ing protein with a negative net charge that is present in
both nuclear and cytoplasmic fractions. These properties
are similar to those of the ELAV-like HuR protein (Ma et
al., 1996). Previous results from our group have shown
that HuR binds to the AU-rich RNA element in the HPV-1
late 39 UTR, but not to an inactive mutant thereof
(Sokolowski et al., 1999). We used the HPV-1 ARE-wt
intact HuR binding sites, or AUM/UM, a mutant of XB which does not
bind to HuR (Sokolowski et al., 1999). The levels of the HuR protein
AND SCHWARTZwere determined by densitometry and plotted against the amounts of
competitor RNA used in each reaction.
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HuR TRNA, previously described as XB (Sokolowski et al.,
1999), and the HPV-1 ARE-MUT RNA, previously de-
scribed as AUM/UM (Sokolowski et al., 1999), as com-
petitors in UV-cross-linking reactions between the HCV
39 UTR and the cytoplasmic extract. The 38-kDa protein
was quantified and the levels were plotted against the
amounts of competitors used in the assay (Fig. 3C). The
wild-type sequence but not the mutant sequence com-
peted efficiently with the HCV 39 UTR probe 39S for the
38-kDa protein, indicating that the 38-kDa protein may be
HuR.
To prove that HuR interacts with the HCV 39 UTR,
nuclear and cytoplasmic proteins that UV-cross-link to
the HCV 39 UTR were subjected to immunoprecipitation
with monoclonal antibody 16A5 against HuR. As can be
seen in Fig. 4A, the anti-HuR monoclonal antibody effi-
ciently immunoprecipitated the 38-kDa protein. Although
the 38-kDa protein can be seen in the postimmunopre-
cipitation supernatants and it could be argued that the
38-kDa band is a mix of two proteins, we believe that the
most likely explanation for this result is that limiting
levels of anti-HuR monoclonal antibody were used in
these experiments. A control serum did not immunopre-
cipitate UV-cross-linked proteins (Fig. 4A, lower panel).
The characterization of two proteins from the 40- to
45-kDa cluster as poly(rU) binding proteins with a posi-
tive net charge and primarily nuclear localization re-
vealed properties similar to those of hnRNP C. Immuno-
precipitation with anti-hnRNP C monoclonal antibody
4F4 detected a 40-kDa protein that UV-cross-links to the
HCV 39 UTR (Fig. 4B). A control monoclonal antibody
toward an unrelated cellular RNA binding protein did not
detect any of the UV-cross-linked proteins (Fig. 4B). In
summary, the UV-cross-linked protein was characterized
with respect to molecular weight, affinity for RNA se-
quences with binding sites to known RNA-binding pro-
teins, affinity for homoribopolymers, and charge at pH
7.6. Based on these findings, selected sera against
known RNA binding proteins were used in immunopre-
cipitation experiments with proteins that had been UV-
cross-linked to HCV RNA sequences. Sera against HuR
and hnRNP C scored positive in the assay. Taken to-
gether, the results demonstrated that HuR and hnRNP C
interact with the HCV 39 UTR.
Recombinant HuR and hnRNP C1 bind to the HCV 39
UTR
To confirm that HuR binds to the HCV 39 UTR, recom-
binant GST-HuR was tested for binding to the HCV 39
UTR. Figure 5A shows that the GST-HuR UV cross-links
to the HCV 39 UTR and that unlabeled HCV 39 UTR RNA
competes with the probe for GST-HuR, whereas the HPV-
1-derived C2 RNA (Sokolowski et al., 1997) does not. GST
BINDING OFlone does not bind to the HCV 39 UTR (data not shown).
sing deletion mutants of the HCV 39 UTR (Fig. 1A) asompetitors, it was confirmed that HuR binds to the
-rich region, and not to the conserved or the variable
egions (Fig. 5B), as expected from the results shown on
he 38-kDa protein in Figs. 2B and 2C. We also confirmed
reviously published results that hnRNP C1 interacts
ith the U-rich region in the HCV 39 UTR (Gontarek et al.,
999) by using recombinant his-tagged hnRNP C (data
ot shown). We concluded that HuR and hnRNP C bind
pecifically to the HCV 39 UTR.
uR and hnRNP C interact with the antisense strand
f the HCV 59 UTR
The UV-cross-linking patterns observed with the HCV
9 UTR and the antisense strand of the HCV 59 UTR were
imilar (Fig. 1B). We therefore investigated if HuR and
nRNP C interacted also with the antisense strand of the
9 UTR. Nuclear extracts were UV-cross-linked to probe
9A (Fig. 1A) which represents the antisense strand of
he HCV 59 UTR followed by immunoprecipitation with
he anti-HuR or anti-hnRNP C monoclonal antibodies
6A5 and 4F4, respectively (Fig. 6A). The results revealed
hat the anti-HuR monoclonal antibody immunoprecipi-
ated the 38-kDa protein (Fig. 6A) and that the anti hnRNP
monoclonal antibody detected a 42-kDa protein (Fig.
B) that binds to the antisense strand of the 59 UTR. A
onoclonal antibody toward an unrelated RNA binding
rotein did not immunoprecipitate the UV-cross-linked
roteins (Figs. 6A and 6B).
To confirm that HuR binds to the antisense strand of
he HCV 59 UTR, radiolabeled RNAs corresponding to the
ense and the antisense strands of the HCV 59 and 39
TRs were subjected to UV-cross-linking with the GST-
uR protein. The results confirmed that HuR binds spe-
ifically to the sense strand of the HCV 39 UTR and to the
ntisense strand of the HCV 59 UTR (Fig. 7A) but not to
he antisense strand of the 39 UTR nor to the sense
trand of the 59 UTR (Fig. 7A), as expected from the
results on the 38-kDa protein shown in Figs. 1B, 1C, and
1D. Similar results were obtained with his-tagged hnRNP
C1 (Fig. 7B). Interestingly, hnRNP C1 also interacted with
the 39A probe (Fig. 7B). It appears that the 39A probe
cross-links more efficiently to 39A than to 39S. However,
UV cross-linking is not a quantitative method and com-
petition experiments are required to compare the affinity
of hnRNP C1 for the two RNA sequences. In contrast, the
his-tagged La protein showed a different pattern and
interacted with the sense strands of the HCV 39 and 59
TRs (Fig. 7C), as expected from previously published
esults (Ali and Siddiqui, 1997; Spångberg et al., 1999),
but not with the antisense strand of the HCV 59 and 39
UTRs (data not shown). These results demonstrated that
the recombinant proteins used here interacted with the
383O HCV RNAvarious probes in a sequence-specific manner.
To further determine the specificity of the protein in-
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each immunoprecipitation. Lower panel: A control immunoprecipitation
with a monoclonal antibody against an unrelated protein. (C) UV cross-
LUND,teractions with the HCV RNA 59A, recombinant HuR was
UV-cross-linked to the antisense strand of the HCV 59
UTR in the absence or presence of the unspecific HPV-1
RNA competitor C2 (Sokolowski et al., 1997) or the spe-
cific HCV 39 UTR RNA competitor 39S. The results re-
ealed that the HCV 39 UTR competed efficiently with the
adiolabeled probe whereas the unspecific C2 RNA com-
etitor did not (Fig. 7D), confirming that HuR interacted
pecifically with the antisense strand of the HCV 59 UTR
nd with the sense strand of the HCV 39 UTR. Similar
esults were obtained with recombinant hnRNP C1 (data
ot shown). In addition, using cytoplasmic cell extracts,
he sense strand of the HCV 39 UTR competed efficiently
ith the probe 59A for the 38- and 42-kDa proteins, but
ot for the 55- and 95-kDa proteins (Fig. 7E). In other
ords, HuR and hnRNP C bind to the 39 ends of HCV
NAs of positive and negative polarities.
Inspection of the 59 UTR antisense sequence identi-
ied short U-rich sequences that were potential binding
ites for HuR and hnRNP C. To determine where in the
CV 59 antisense RNA HuR and hnRNP C bind, two RNA
eletion mutants named 59DA and 59DB (Fig. 1A) were
enerated and tested in UV cross-linking with recombi-
ant HuR and hnRNP C1. The results revealed that both
uR and hnRNP C1 were detected with probe 59DB
Figs. 8A and 8B). HuR and hnRNP C bound weaker to
he deletion mutant than to probe 59A. It is likely that the
inding sites for HuR and hnRNP C1 are parts of the
trong secondary structure of the HCV 59 UTR and are
fficiently exposed to proteins only in the context of the
omplete structure. Alternatively, the proteins interact
ith multiple sites. A potential HuR and hnRNP C binding
ite in the 59DB RNA is shown (Fig. 8C).
linking of each extract to the HCV RNA probe 39S; (P) immunoprecipi-
tated sample; (S) supernatant from each immunoprecipitation. (B) Im-
munoprecipitation of one of the 40- to 45-kDa proteins that UV-cross-
link to the HCV RNA probe 39S with anti hnRNP C monoclonal antibody
4F4. Immunoprecipitation reactions were performed with nuclear ex-
tract (NE). The immunoprecipitated hnRNP C protein is indicated. (C)
UV cross-linking of nuclear extract to the HCV RNA probe 39S; (P1)
immunoprecipitation with monoclonal antibody against an unrelated
protein; (S1) supernatant from the same immunoprecipitation; (P2)
immunoprecipitation with anti-hnRNP C monoclonal antibody; (S2) su-
pernatant from the same immunoprecipitation. linking of each extract to
the HCV RNA probe 39S; (P) immunoprecipitated sample; (S) superna-
tant from each immunoprecipitation. (B) Immunoprecipitation of one of
the 40- to 45-kDa proteins that UV-cross-link to the HCV RNA probe 39S
with anti hnRNP C monoclonal antibody 4F4. Immunoprecipitation
reactions were performed with nuclear extract (NE). The immunopre-
cipitated hnRNP C protein is indicated. (C) UV cross-linking of nuclear
extract to the HCV RNA probe 39S; (P1) immunoprecipitation with
monoclonal antibody against an unrelated protein; (S1) supernatant
from the same immunoprecipitation; (P2) immunoprecipitation with
AND SCHWARTZFIG. 4. (A) Immunoprecipitation of the 38-kDa protein that UV-cross-
links to the HCV RNA probe 39S with anti HuR monoclonal antibody
16A5. Immunoprecipitation reactions were performed with both HeLa
nuclear (NE) and cytoplasmic extracts (CE). The immunoprecipitated
p38-HuR protein and the p40- to 45-kDa proteins detected with the 39S
probe are indicated. (C) UV cross-linking of each extract to the HCV
RNA probe 39S; (P) immunoprecipitated sample; (S) supernatant from
384 SPÅNGBERG, WIKanti-hnRNP C monoclonal antibody; (S2) supernatant from the same
immunoprecipitation.
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m .DISCUSSION
Cellular factors interacting with the HCV 39 UTR have
een described previously (Yen et al., 1995). For example,
uo identified a 35-kDa protein and a 58-kDa protein that
ind to the U-rich region of the HCV 39 UTR (Luo, 1999).
he 58 kDa was shown to bind to both the U-rich region
nd the conserved region and was identified as PTB,
hereas the 35-kDa protein remained unidentified. Gon-
arek et al. identified a 35- and a 58-kDa protein that both
nteract with the U-rich region (Gontarek et al., 1999).
hile the 58-kDa protein was shown to be PTB, the
5-kDa protein was identified as hnRNP C. Tsuchihara
dentified a major 57-kDa protein that UV-cross-linked to
he HCV 39 UTR (Tsuchihara et al., 1997). This protein
as identified as PTB and the binding site was mapped
o the conserved region in the 39 UTR. In addition, results
resented by these authors also demonstrated the bind-
ng of proteins between 30 and 42 kDa that bound pref-
rentially to a specific competitor and not to tRNA. Ito et
l. identified a 58-kDa protein that interacted with the
onserved region of the HCV 39 UTR and that was iden-
ical to PTB (Ito and Lai, 1997). In addition they detected
hree minor proteins of which one is 39 kDa. Multiple
roteins interact with the HCV UTR (Lai, 1998) and sev-
ral investigators have observed that proteins in the
0–40 kDa size range UV-cross-link to the HCV 39 UTR.
urther work is needed to determine the relationship
FIG. 5. (A) Threefold serially diluted unlabeled HCV 39S RNA or C2
ate 39 UTR, were used as competitors in UV-cross-linking reactions
ompetitor over probe was 3-, 9-, 27-, and 81-fold. (2) UV cross-linking
ross-linking of GST-HuR to the 39S probe in the absence (2) or prese
olar excess of the competitor over probe was 3-, 9-, 27-, and 81-fold
BINDING OFmong the various described HCV RNA binding proteins.
HuR and ELAV-like proteins bind AU-rich RNA insta-
a
pility elements on cellular and viral mRNAs (Good, 1997;
eene, 1999). These are U-rich sequences sometimes
ontaining the AUUUA motif that are associated with
hort RNA half-life and inefficient translation (Ross,
995). However, some elements do not contain the
UUUA sequence and HuR has been shown to bind also
o U-rich sequences that lack this motif with high affinity.
nucleotides appear to constitute essential parts of the
uR binding site on the mRNAs. The HCV 39 UTR se-
uence used here lacks AUUUA motifs but contains a
equence consisting of primarily U nucleotides inter-
upted only by C nucleotides. Mutational analysis and
toichiometric measurements are required to determine
he exact binding site of HuR and the number of HuR
inding sites in the U-rich region in the HCV 39 UTR RNA.
uR and hnRNP C are the only proteins so far that have
een shown to bind to the 39 ends of HCV RNAs of both
olarities (Fig. 9). The binding sites in the HCV 39 UTR
1) were located in the U-rich region and the binding
ites in the HCV 39 end of the RNA strand of negative
olarity were located in the very 39 end of the RNA.
The HuR protein has a unique signal for nuclear import
nd export which confers a shuttling function to HuR
Atasoy et al., 1998; Fan and Steitz, 1998a,b; Peng et al.,
998). The levels of HuR in the cell cytoplasm are deter-
ined by the differentiation stage of the cell and is
ependent on the cell cycle. It is therefore reasonable to
okolowski et al., 1997), derived from the human papillomavirus type 1
en radiolabeled probe 39S and GST-HuR. The molar excess of the
-HuR to the RNA probe 39S in the absence of competitor RNA. (B) UV
the indicated deletion mutant RNAs named V, UC, and C (Fig. 1A). The
385O HCV RNARNA (S
betwe
of GST
HuR Tssume that HuR plays an important role in the cyto-
lasm and therefore may be involved in the HCV repli-
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LUND,cation cycle. In contrast, the hnRNP C protein is strictly
nuclear (Nakielny and Dreyfuss, 1996) and has been
implicated in RNA splicing and polyadenylation
(Weighardt et al., 1996). It is therefore unclear if hnRNP C
and HCV RNA interact in the HCV-infected cells. On the
other hand, there is at least one example of redistribution
of nuclear factors to the cytoplasm in virus-infected cells,
thereby allowing viral RNAs to come in contact with
nuclear factors. This was suggested to occur for the
Coronavirus mouse hepatitis virus and hnRNP A1 (Li et
FIG. 6. (A) Immunoprecipitation of the 38-kDa protein that UV-cross-
links to the HCV RNA probe 59A with anti-HuR monoclonal antibody
16A5. Immunoprecipitation reactions were performed with HeLa nu-
clear extracts (NE). The immunoprecipitated HuR protein is indicated.
(C) UV cross-linking of nuclear extract to the HCV RNA probe 59A; (P1)
immunoprecipitation with anti HuR monoclonal antibody; (S1) superna-
tant from the same immunoprecipitation; (P2) immunoprecipitation with
monoclonal antibody against an unrelated protein; (S2) supernatant
from the same immunoprecipitation. (B) Immunoprecipitation of one of
the 40- to 45-kDa proteins that UV-cross-link to the HCV RNA probe 59A
with anti hnRNP C monoclonal antibody 4F4. Immunoprecipitation
reactions were performed with nuclear extract. The immunoprecipi-
tated hnRNP C protein is indicated. (C) UV cross-linking of nuclear
extract to the HCV RNA probe 39S; (P1) immunoprecipitation with
monoclonal antibody against an unrelated protein; (S1) supernatant
from the same immunoprecipitation; (P2) immunoprecipitation with
anti-hnRNP C monoclonal antibody; (S2) supernatant from the same
immunoprecipitation.
386 SPÅNGBERG, WIKal., 1997). HCV interacts with nuclear factors such as PTB
(Chung and Kaplan, 1999; Gontarek et al., 1999; Ito and
t
mLai, 1997, 1999; Luo, 1999; Tsuchihara et al., 1997),
hnRNP L (Hahm et al., 1998), and hnRNP C (Gontarek et
al., 1999; and this manuscript) and infection of HCV may
alter the subcellular distribution of these proteins,
thereby allowing interactions between the nuclear fac-
tors and the HCV RNA. Similarly to hnRNP A1, the HuR
protein is a shuttling protein (Atasoy et al., 1998; Fan and
Steitz, 1998a,b; Peng et al., 1998) and HCV may affect the
subcellular distribution of HuR by the same mechanism
as mouse hepatitis virus affects hnRNP A1 (Li et al.,
1997).
On cellular mRNAs, HuR binds to AU-rich sequences
that mediate rapid mRNA degradation. However, overex-
pression of HuR in transfected cells appears to prevent
premature degradation of hybrid mRNAs containing the
c-fos or GM-CSF mRNA instability determinants (Fan and
Steitz, 1998b; Peng et al., 1998). The first step in the
degradation of cellular mRNAs is deadenylation, fol-
lowed by degradation of the RNA (Ross, 1995). It has
recently been shown that HuR protects deadenylated
RNA from degradation in vitro (Ford et al., 1999). Similarly,
hnRNP C has been shown to protect RNAs from degra-
dation in vitro (Rajagopalan et al., 1998). Since HCV
RNAs lack a poly(A) tail, one may speculate that HuR
binds to the 39 ends of HCV RNAs of both polarities and
protect the mRNAs from premature degradation. The
inefficient replication of HCV in vitro makes it difficult to
assess the role of the RNA binding proteins in HCV
replication. We were unable to demonstrate specific ef-
fects of HuR on the half-life of HCV mRNAs, suggesting
that HuR may affect other processes in the HCV replica-
tion cycle. In vitro synthesized RNAs of subgenomic HCV
mRNAs encompassing the HCV 59 UTR, the capsid cod-
ing sequence followed by a translational stop codon, and
the HCV 39 UTR were either first allowed to bind in vitro
o purified his-tagged or GST-HuR fusion protein and
hen electroporated into cells as RNA-protein complexes
r cotransfected with capped and polyadenylated, in
itro synthesized HuR encoding mRNAs that produce
igh levels of HuR. However, in none of the experiments
ere we able to demonstrate an effect on the HCV
RNA half-life by the HuR protein. We speculate that
uR may be involved in replication of the HCV genome.
After a first round of translation, the HCV RNA which
nters the infected cell is subjected to transcription by
he HCV encoded RNA-dependent RNA polymerase
S5b. HCV RNA synthesis commences after localization
f the RNA polymerase to the HCV 39 UTR. The synthe-
ized minus strand serves as template for the synthesis
f new plus-strand RNA molecules, starting from the 39
nd of the minus-strand RNA molecule. Since the 39 ends
f HCV RNAs of positive and negative polarities consti-
ute start sites for the HCV polymerase, proteins that bind
o the ends of both RNA strands may be involved in
AND SCHWARTZranscription initiation. Therefore, HuR and/or hnRNP C
ay be involved in HCV RNA transcription and may act
Gpreviously to bind (Sokolowski et al., 1997). The structures of the RNA
probes are shown in Fig. 1A. (B) UV cross-linking of partially purified
HuR Tby recruiting the polymerase complex to the HCV RNA,
perhaps by directly interacting with the NS5b polymer-
ase or other components of the transcription complex.
Further work is required to elucidate the roles of HuR
and hnRNP C in the HCV life cycle.
MATERIALS AND METHODS
Plasmids
The following plasmids have been described previ-
ously pCRHCV3UTRS:2 (Spångberg et al., 1999), pKSV
(Spångberg et al., 1999), pKSUC (Spångberg et al., 1999),
pKSC (Spångberg et al., 1999), p5UTR(S):21 (Spångberg
and Schwartz, 1999), and pKSC2 (Sokolowski et al., 1997).
To generate pCRHCV3UTRA, the HCV 39 UTR was first
PCR-amplified from the infectious clone pCV-H77C (Yanagi
et al., 1997) with oligonucleotides HCV3UTRS (59-GATATCG-
TACCGCAGGGGTAGGCATCTA-39) and HCV3UTRA (59-
FIG. 8. His-hnRNP C (A) or His-HuR (B) was UV-cross-linked to the
HCV RNA probe 59A and the two deletions mutants thereof named
59DA and 59DB (Fig. 1A). (C) A potential HuR and hnRNP C binding site
present in both RNA probes 59A and 59DB is shown.
His-hnRNP C protein to the HCV RNA probes 39S, 39A, 59S, and 59A as
indicated in the figure. (C) UV cross-linking of partially purified His-La
protein to the HCV RNA probes 59S and 39S. (D) Threefold serially
diluted unlabeled HCV 39S RNA or C2 RNA, derived from the human
papilloma virus type 1 late 39 UTR, was used as competitors in UV
cross-linking reactions between radiolabeled probe 59A and His-HuR.
The molar excess of the competitor over probe was 3-, 9-, 27-, and
81-fold. (2) UV cross-linking of GST-HuR to the RNA probe 59A in the
absence of competitor RNA. (E) Threefold serially diluted unlabeled
HCV 39S or 39A RNA were used as competitors in UV cross-linking
reactions between radiolabeled probe 59A and HeLa cell cytoplasmic
extract. The molar excess of the competitor over probe was 3-, 9-, 27-,
and 81-fold. (2) UV cross-linking of cytoplasmic extract to the RNA
387O HCV RNAFIG. 7. (A) UV cross-linking of partially purified GST-HuR protein to
the HCV RNA probes 39S, 39A, 59S, and 59A and to the HPV-1 RNA probe
XB (Sokolowski et al., 1997), as indicated in the figure. The XB probe is
included as a positive control to which GST-HuR has been shown
BINDING OFprobe 59A in the absence of competitor RNA. The 38-kDa HuR protein
is indicated.
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LUND,CGTCGACATGATCTGCAGAGAGG-39). The 256-nt fragment
was inserted in the antisense orientation after the T7
promoter in the pCR2.1 vector (Invitrogen). p5UTS:21
(Spångberg and Schwartz, 1999) was cleaved with
EcoRV and BamHI and the released fragment was in-
erted into an EcoRV- and BamHI-digested pBlue-
criptKS- plasmid (Stratagene), resulting in pKS59UTR(A):2
ith the HCV 59 UTR in the antisense orientation down-
tream of the T7 promoter. Deletions in the 59 UTR
ere generated by digestion of pKS59UTR(A):2 with StuI
nd XhoI or BamHI and StuI, followed by fill in of 39 ends
ith Klenow fragment and religation, generating
KS59UTRdelA:5 and pKS59UTRdelB:8, respectively.
he HuR coding sequence was PCR-amplified with
ligonucleotides NHEIHuR(S) (59-GGTATGGCTAGCATG-
CTAATGGTTAT-39) and HindIIIHuR(A) (59-AAAGCTTA-
TTGTGGGAC-39) and subcloned into pCR3.1-Uni (In-
itrogen). The HuR sequence was released by digest-
on with NheI and HindIII and inserted into pTrcHisB
Invitrogen), resulting in pTrcHisHur. The La coding
equence was PCR-amplified with oligonucleotides
AS:1 (59-ACCATGGGGGGTTCTCATCATCATCATCATC-
TGCTGAAAATGGTGATAAT39) and LAA:1 (59-AAGCTTC-
ACTGGTCTCCAGCACC-39) and subcloned into EcoRV-
igested pBluescriptKS- (Stratagene). The La sequence
as released by digestion with NcoI and HindIII and
nserted into pTrcHisB (Invitrogen), resulting in pTrcHisB/
a. pHis-hnRNP C1 was a gift from W. M. LeStourgeon
nd pGEX-HuR was a gift from H. Furneaux (Ma et al.,
996).
ell extracts and fractionation
HeLa and Hep3B nuclear and cytoplasmic extracts
FIG. 9. A schematic drawing of the known cellular HCV RNA binding
proteins PTB (Chung and Kaplan, 1999; Gontarek et al., 1999; Ito and
Lai, 1997, 1999; Luo, 1999; Tsuchihara et al., 1997), La (Ali and Siddiqui,
1997; Spångberg et al., 1999), PCBP (Spångberg and Schwartz, 1999),
hnRNP L (Hahm et al., 1998), eIF3 (Pestova et al., 1998; Sizova et al.,
1998), HuR (this manuscript), and hnRNP C (Gontarek et al., 1999; and
this manuscript). HCV RNA strands of both polarities are shown. The
box represents the HCV polyprotein coding region.
388 SPÅNGBERG, WIKere prepared according to the method of Dignam (Dig-
am et al., 1983), as described previously (Zhao et al.,
d
o996). Cytoplasmic extracts from primary hepatocytes
ere prepared from a human liver biopsy by homogeni-
ation in lysis buffer (60 mM KCl, 10 mM HEPES, pH 7.6,
mM MgCl2, 1% NP-40, 20% glycerol, and 5 mg/ml apro-
tinin) followed by centrifugation at 14,000 g for 3 min. The
supernatants were collected and used here as cytoplas-
mic liver cell extracts. Liver cytoplasmic extract (10 mg)
was diluted 1:2 with loading buffer Q (20 mM Tris, pH 7.5,
10% glycerol, 1 mM EDTA, 1 mM DTT, 0.2 M NaCl) and
applied to a HiTrap Q column (Pharmacia Biotech) and
the flowthrough fraction was collected. Alternatively, 20
mg of the liver cell extract was diluted 1:4 in loading
buffer SP (20 mM NaH2PO4, pH 6.6, 1 mM DTT, 1 mM
EDTA, 10% glycerol, 0.1 M NaCl, and 3 mM EDTA) and
applied to a HiTrap SP column (Pharmacia Biotech) and
the flowthrough fraction was collected.
Purification of GST-HuR, His-hnRNP C1, His-La, and
His-HuR
Purified GST-HuR protein was prepared by using glu-
tathionine-Sepharose (GS) beads according to the man-
ufacturer’s instructions (Pharmacia Biotech). Briefly, a
400-ml culture of DH5 cells transformed with pGEX-HuR
(Ma et al., 1996) was induced with IPTG (0.1 mM) for 2 h
at 37°C. Bacterial cultures were centrifuged in a Beck-
man centrifuge at 6000 g. The pellets was resuspended
in ice-cold phosphate-buffered saline (PBS) and lysed by
30-s bursts of sonication followed by incubation on ice in
1% Triton X-100. Cell debris was removed by centrifuga-
tion and GST-HuR was purified from the supernatant
using GS beads. The protein concentration was deter-
mined by comparison with a serial dilution of BSA on
Coomassie-stained sodium dodecyl sulfate-polyacrylam-
ide (SDS-PAGE) gels.
His-hnRNP C1, His-La, and His-HuR proteins were
prepared by using HiTrap chelating columns according
to the manufacturer’s instructions (Pharmacia Biotech)
with minor changes. Briefly, a 400-ml culture of bacterial
cells transformed with the appropriate plasmid was in-
duced with IPTG (0.1 mM) for 2 h at 37°C. The cells were
pelleted in a Beckman centrifuge at 6000 g. The pellets
were resuspended in ice-cold PBS and lysed by 30-s
bursts of sonication followed by incubation in 1% Triton
X-100 on ice. Cell debris was removed by centrifugation
and the supernatants were filtered through a 0.45-mm
filter and loaded onto HiTrap chelating columns. Bound
proteins were eluted with EDTA-phosphate buffer, pH 7.4
(1 mM Na2HPO4, 1 mM, NaH2PO4, 50 mM NaCl) with the
ollowing different concentrations of EDTA: 20, 40, 60,
nd 100 mM, respectively. The protein concentration was
AND SCHWARTZetermined by comparison with a serial dilution of BSA
n Coomassie-stained SDS-PAGE gels.
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HuR TIn vitro transcription and UV cross-linking
In vitro synthesis of radiolabeled and unlabeled
NA was performed on linearized plasmid DNA.
CRHCV3UTRS:2, pCRHCV3UTRA, and p5UTS:21 were
inearized with SpeI and yielded RNAs 39S, 39A, and 59S;
pKSV and pKSUC were linearized with HindIII and
yielded RNAs V and UC; and pKSC was linearized with
EcoRI and yielded RNA C. pKS59UTR(A) and
pKS59UTRdelA:5 were linearized with EcoRV and pro-
duced RNAs 59A and 59DA; and pKS59UTRdelB:8 was
linearized with KpnI and produced RNA 59DB. In vitro
ranscription was performed with either T3- or T7-RNA
olymerase in the presence of [32P]UTP or [32P]CTP as
previously described (Zhao et al., 1996). The radiolabeled
RNAs were purified by EtOH precipitation and the RNAs
were resuspended in water.
UV cross-linking was carried out essentially as de-
scribed previously (Zhao et al., 1996), with some modifi-
cations. Briefly, recombinant protein or cell extract was
incubated with radiolabeled RNA (105 dpm) in binding
buffer (60 mM KCl, 10 mM HEPES, pH 7.6, 3 mM MgCl2,
1 mM DTT, 5% glycerol, and 5 ml/mg heparin) in the
absence or presence of unlabeled competitor RNA. In
competition experiments, the unlabeled RNAs were
mixed with protein or cell extract under binding condi-
tions and binding was allowed to occur for 10 min at
room temperature prior to addition of radiolabeled RNA.
The probe was allowed to bind to proteins for 15 min at
room temperature followed by UV irradiation in a Strat-
agene linker (Stratagene) for 5 min at 800 mJ. After UV
irradiation, the samples were digested with RNaseA for
20 min at 37°C. The UV-cross-linked RNA proteins were
resolved on 12% SDS-PAGE gels and bands were visu-
alized by autoradiography.
Antibodies and immunoprecipitation
For immunoprecipitations, three parallel UV-cross-link-
ing reactions were diluted up to 100 ml with radioimmu-
noprecipitation assay (RIPA) buffer (25 mM Tris-HCl, pH
7.4, 75 mM NaCl, 0.5% Triton X-100, 0.5% sodium deoxy-
cholate, and 0.05% SDS) followed by the addition of
monoclonal antibody. Monoclonal antibodies were 16A5
against HuR (generously provided by H. Furneaux), 4F4
against hnRNP C (generously provided by R. Dreyfuss),
or control monoclonal antibodies that did not react with
HCV RNA binding proteins (mab 104 against SR proteins
and mab 2.73 against U1-70K). The samples were incu-
bated for 2 h at 4°C prior to the addition of protein
A-Sepharose and continued incubation for 1 h at 4°C.
The beads were washed three times in RIPA buffer and
resuspended in 20 ml of water mixed with 20 ml of 53
DS loading buffer (625 mM Tris-HCl, pH 6.8, 6.25% SDS,
0% glycerol, and 20% b-mercaptoethanol). The samples
BINDING OFwere boiled prior to the loading on the 12% SDS-PAGE
gels. Bands were visualized by autoradiography.ACKNOWLEDGMENTS
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